Phorbol

Phorbol

SCHEMBL29445678

CC1=C[C@H]2[C@@]3(O)[C@H](C)[C@@H](O)[C@]4(O)[C@H]([C@@H]3C=C(CO)C[C@@]2(O)C1=O)C4(C)C

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 5/20 0.60
PRKCG P05129 5/20 0.60
PRKD3 O94806 4/20 0.60
PRKCB P05771 4/20 0.60
PRKCH P24723 4/20 0.60
PRKCI P41743 4/20 0.60
PRKCE Q02156 4/20 0.60
PRKCQ Q04759 4/20 0.60
PRKCZ Q05513 4/20 0.60
PRKCD Q05655 4/20 0.60
PRKD1 Q15139 4/20 0.60
VAV1 P15498 2/20 0.58
USP2 O75604 2/20 0.53
TP53 P04637 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phorbol SCHEMBL15976176 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL2329457 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL1733926 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL3403135 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL5667270 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL12950512 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL14937 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL8190878 1.00 PRKCA (0.60) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL23880303 0.99 PRKCA (0.59) PRKCAPRKCGPRKD3PRKCBPRKCH
Phorbol SCHEMBL5310296 0.99 PRKCA (0.59) PRKCAPRKCGPRKD3PRKCBPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072196-A1 METHODS FOR CULTURING AND ASSAYING B CELL LYMPHOCYTES BRUKER CELLULAR ANALYSIS, INC. (US) 2025-04-03 WO claimed
WO-2025072196-A1 METHODS FOR CULTURING AND ASSAYING B CELL LYMPHOCYTES BRUKER CELLULAR ANALYSIS, INC. (US) 2025-04-03 WO disclosed
EP-4427028-A2 METHODS TO QUANTIFY AFFINITY AND SELECTIVITY OF COMPOUNDS FOR PROTEINS IN LIVING CELLS Ohio State Innovation Foundation (US) 2024-09-11 EP disclosed
CN-116478842-A Recombinant saccharomyces cerevisiae strain for producing (+) -phoropterygii and preparation method thereof 中国人民解放军军事科学院防化研究院 2023-07-25 CN disclosed
US-20230146870-A1 METHOD TO QUANTIFY AFFINITY AND SELECTIVITY OF SMALL MOLECULES FOR PROTEINS IN LIVING CELLS OHIO STATE INNOVATION FOUNDATION 2023-05-11 US disclosed
WO-2023081804-A1 PLATELET DERIVATIVE COMPOSITIONS, AND METHODS OF MAKING AND USING SUCH COMPOSITIONS CELLPHIRE, INC. (US) 2023-05-11 WO disclosed
WO-2023077162-A2 METHODS TO QUANTIFY AFFINITY AND SELECTIVITY OF COMPOUNDS FOR PROTEINS IN LIVING CELLS OHIO STATE INNOVATION FOUNDATION (US) 2023-05-04 WO disclosed
CN-115066492-A Method for producing hematopoietic stem cells 布里格姆妇女医院 2022-09-16 CN disclosed
WO-2022192521-A1 SYNTHESIS OF TIGILANOL TIGLATE AND ANALOGS THEREOF THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2022-09-15 WO disclosed
CN-114317669-A Method for screening drugs based on intracellular protein kinase C activation state and high-throughput screening device 北京大学 2022-04-12 CN disclosed
CN-114072159-A Materials and methods for producing blood products 塞尔菲乐有限公司 2022-02-18 CN disclosed